Results 221 to 230 of about 76,145 (237)

Ceftolozane–tazobactam versus meropenem for treatment of nosocomial pneumonia (ASPECT-NP): a randomised, controlled, double-blind, phase 3, non-inferiority trial

Lancet Infectious Diseases, The, 2019
Marin H Kollef, Alvaro Rea-Neto, Nobuaki Shime   +2 more
exaly  

Pharmacokinetic evaluation of piperacillin-tazobactam

Expert Opinion on Drug Metabolism and Toxicology, 2010
Jason A Roberts, David L Paterson, Jeffrey Lipman   +2 more
exaly  

Piperacillin/tazobactam

Reactions Weekly, 2018
openaire   +1 more source

Ceftolozane-tazobactam compared with levofloxacin in the treatment of complicated urinary-tract infections, including pyelonephritis: a randomised, double-blind, phase 3 trial (ASPECT-cUTI)

Lancet, The, 2015
exaly  

Comparison of the Incidence of Vancomycin‐Induced Nephrotoxicity in Hospitalized Patients with and without Concomitant Piperacillin‐Tazobactam

Pharmacotherapy, 2014
Richard H Drew
exaly  

Tazobactam

RCSB Protein Data Bank
openaire   +1 more source

Piperacillin–Tazobactam

2010
openaire   +1 more source

Ceftolozane/tazobactam activity tested against Gram-negative bacterial isolates from hospitalised patients with pneumonia in US and European medical centres (2012)

International Journal of Antimicrobial Agents, 2014
David J Farrell, Helio S Sader, Ronald N. Jones   +2 more
exaly  

Piperacillin/tazobactam

Reactions Weekly, 2006
openaire   +1 more source

Risk of Acute Kidney Injury in Patients on Concomitant Vancomycin and Piperacillin–Tazobactam Compared to Those on Vancomycin and Cefepime

Clinical Infectious Diseases, 2017
Keith S Kaye, Jason M Pogue, Shantanu Solanki   +2 more
exaly